News & Media

SEPTEMBER 17, 2007

Trius Presents Study Results of Best-in-Class Antibiotics in 11 Posters at ICAAC

JULY 11, 2007

Trius Therapeutics Recruits former J&J Clinician as Chief Medical Office

JUNE 4, 2007

Trius Therapeutics Recruits Merck Executive to Lead Drug Development Efforts

FEBRUARY 27, 2007

Trius Therapeutics Completes $20 Million Series A Financing and Names CEO

FEBRUARY 27, 2007

Trius Therapeutics Enters into License Agreement with Dong-A Pharmaceuticals for Novel Anti-bacterial Agent

SEPTEMBER 27, 2006

Rx3 Pharmaceuticals Expands Board of Directors

SEPTEMBER 26, 2006

Rx3 Pharmaceuticals Creates New Clinical Advisory Board

SEPTEMBER 25, 2006

Rx3 Pharmaceuticals Awarded Two New NIH Grants Totaling $1.5 Million

JULY 28, 2006

People to watch: Jeffrey Stein

JULY 27, 2006

Rx3 Pharmaceuticals Expands Board and Management Team

JANUARY 03, 2005

Rx3 Pharmaceuticals Expands Management Team

AUGUST 26, 2004

Rx3 Pharmaceuticals Officially Launched

JULY, 2004

IDSA - Bad Bugs, No Drugs. As Antibiotic Discovery Stagnates ... A Public Health Crisis Brews

March 24, 2008

Trius Raises $30 Million in Series B Financing

January 7, 2008

Trius Initiates U.S. Phase I Trial for its Oxazolidinone
Antibacterial Drug, Torezolid